Management of Constipation
For chronic idiopathic constipation in adults, start with polyethylene glycol (PEG) 17g daily as first-line pharmacological therapy, which has a strong recommendation with moderate certainty of evidence and proven durability over 6 months. 1
Stepwise Treatment Algorithm
Step 1: Initial Conservative Measures (Mild Constipation)
Fiber supplementation can be considered for mild constipation, particularly in patients with low dietary fiber intake 1
Fluid intake: Only increase in patients with documented low baseline fluid intake (lowest quartile) 1
Step 2: First-Line Pharmacological Therapy
Polyethylene Glycol (PEG) - STRONG RECOMMENDATION 1
- Dose: 17g daily, mixed in 8 ounces of liquid
- Mechanism: Osmotic laxative
- Evidence: Increases complete spontaneous bowel movements by 2.90 per week (moderate certainty) 1
- Duration: Proven effective and durable over 6 months 1
- Cost: $10-45/month 1
- Side effects: Abdominal distension, loose stool, flatulence, nausea
- Titration: Adjust based on symptom response; no clear maximum dose 1
Alternative osmotic laxatives (if PEG unavailable or not tolerated):
- Lactulose 15g daily (conditional recommendation; only osmotic studied in pregnancy) 1
- Magnesium oxide 400-500mg daily (conditional recommendation; caution in renal insufficiency) 1
Step 3: Stimulant Laxatives (Short-term or Rescue Therapy)
Sodium picosulfate - STRONG RECOMMENDATION 1
- Recommended for short-term use or rescue therapy
- Bisacodyl 5mg daily (can increase to 10mg) 1
- Senna 8.6-17.2mg daily (conditional recommendation) 1
- Important caveat: Long-term safety and efficacy unknown; prolonged use can cause electrolyte imbalance 1
Step 4: Prescription Secretagogues (Inadequate Response to OTC Options)
All have STRONG recommendations 1:
Linaclotide
- Dose: 72-145μg daily (max 290μg)
- Cost: ~$523/month 1
- Additional benefit: May help abdominal pain
- Mechanism: Intestinal secretagogue (guanylate cyclase-C agonist)
Plecanatide
- Dose: 3mg daily
- Cost: ~$526/month 1
- Additional benefit: Also approved for IBS-C
Lubiprostone (conditional recommendation)
- Dose: 24μg twice daily
- Cost: ~$374/month 1
- Mechanism: Chloride channel type 2 activator
- Additional benefit: May help abdominal pain
Step 5: Prokinetic Agent
Prucalopride - STRONG RECOMMENDATION 1
- Dose: 1-2mg daily (max 2mg)
- Cost: ~$563/month 1
- Mechanism: Serotonin type 4 (5-HT4) agonist
- Additional benefit: May help abdominal pain
- Side effects: Headaches, diarrhea in subset of patients
Evidence-Based Dietary Additions
Beyond fiber, specific foods have emerging evidence 2, 3, 4:
- Prunes: 85% of patients report symptom relief 3
- Kiwifruits: Multiple RCTs support efficacy 2, 4
- High mineral-content water: Evidence from systematic reviews 2, 4
- Rye bread: Supported by RCTs 2, 4
Key Clinical Pitfalls to Avoid
- Don't recommend generic "insoluble fiber" - can worsen symptoms; psyllium (soluble) has best evidence 1, 4
- Don't use stimulant laxatives long-term - reserve for rescue therapy only 1
- Don't increase fluids indiscriminately - only beneficial in patients with low baseline intake 1
- Don't use magnesium oxide in renal insufficiency - risk of hypermagnesemia 1
- Don't overlook cost - PEG ($10-45/month) vs. secretagogues ($374-563/month) when efficacy may be similar 1
Treatment Selection Framework
Start with PEG (strong recommendation, affordable, proven durability) → Add or switch to stimulant laxative for rescue → Escalate to prescription secretagogues or prucalopride if inadequate response to OTC options and cost is acceptable → Consider physiological testing for refractory cases to identify defecatory disorders 5, 6
The 2023 AGA-ACG guidelines provide the most comprehensive, evidence-based framework with 10 specific recommendations using GRADE methodology 1. The strength of recommendation for PEG is based on moderate certainty evidence showing significant improvement in bowel movements with durable response over 6 months 1, making it the optimal first-line pharmacological choice after conservative measures.